rituximab and salvage therapies for patients with itp
Published 5 years ago • 7.4K plays • Length 9:11Download video MP4
Download video MP3
Similar videos
-
5:15
first-line therapy options for patients with itp
-
4:44
second-line treatment options for patients with itp
-
6:53
immunosuppressive therapy in itp
-
10:40
strategies for managing immune thrombocytopenia
-
4:33
risk of thrombosis in patients with itp
-
6:59
itp treatment selection criteria and treatment goals
-
6:44
the future of itp treatment
-
21:06
#109 finally tried rituxan, ivig for platelets / itp
-
3:46
when to initiate treatment for itp
-
4:14
long-term safety and efficacy of sutimlimab for chronic itp
-
5:34
treating refractory idiopathic thrombocytopenic purpura (itp)
-
6:45
treatment of steroid-refractory immune thrombocytopenia
-
2:30
practical considerations for subcutaneous rituximab
-
5:28
treatment of idiopathic thrombocytopenic purpura (itp)
-
1:28
a defiant message for all who live with immune thrombocytopenia (itp)
-
2:38
itp patient management and important treatment factors
-
6:46
considerations for treating itp in the future
-
4:55
anxiety in adult patients living with itp stratified across different treatment types and groups
-
3:33
frontline therapy for immune thrombocytopenia